Description
To support the rapidly expanding biologics market, our Antibody Drug Design Services specialize in the in silico engineering of highly specific antibody therapeutics. Our computational capabilities encompass epitope mapping, antibody humanization to minimize immunogenicity, affinity maturation to boost targeting power, and developability profiling (such as aggregation and solubility prediction). This tailored platform supports various formats including monoclonal antibodies, bispecifics, and fragments.